Literature DB >> 18821083

Deep brain stimulation for parkinsonian gait disorders.

Andres M Lozano1, Brian J Snyder.   

Abstract

The cardinal motor manifestation of Parkinson's disease (PD) is being treated with greater and greater efficacy with both newer medications as well as both subthalamic nucleus (STN) and globus pallidus internus (GPI) deep brain stimulation (DBS). The burden of disease is shifting towards the non-dopaminergic disease manifestations including gait and posture. Based on evidence in the literature and in animal models, recent trials are underway to examine the effects of pedunculopontine nucleus DBS on the treatment of parkinsonian gait disorder. We review the rationale behind this treatment and the status of the current trials.

Entities:  

Mesh：

Year:  2008        PMID： 18821083     DOI： 10.1007/s00415-008-4005-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  11 in total

1.  Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

Authors:  Alessandro Stefani; Andres M Lozano; Antonella Peppe; Paolo Stanzione; Salvatore Galati; Domenicantonio Tropepi; Mariangela Pierantozzi; Livia Brusa; Eugenio Scarnati; Paolo Mazzone
Journal:  Brain       Date:  2007-01-24       Impact factor: 13.501

2.  Pedunculopontine nucleus microelectrode recordings in movement disorder patients.

Authors:  Moran Weinberger; Clement Hamani; William D Hutchison; Elena Moro; Andres M Lozano; Jonathan O Dostrovsky
Journal:  Exp Brain Res       Date:  2008-03-18       Impact factor: 1.972

3.  The mesencephalic locomotor region. I. Activation of a medullary projection site.

Authors:  E Garcia-Rill; R D Skinner
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

4.  The mesencephalic locomotor region. II. Projections to reticulospinal neurons.

Authors:  E Garcia-Rill; R D Skinner
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

5.  [Control of walking and running by means of electric stimulation of the midbrain].

Authors:  M L Shik; F V Severin; G N Orlovskiĭ
Journal:  Biofizika       Date:  1966

6.  Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  I J Mitchell; C E Clarke; S Boyce; R G Robertson; D Peggs; M A Sambrook; A R Crossman
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

Review 7.  The pedunculopontine nucleus and Parkinson's disease.

Authors:  P A Pahapill; A M Lozano
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

8.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

9.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

10.  Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus.

Authors:  Dipankar Nandi; Tipu Z Aziz; Nir Giladi; Jonathan Winter; John F Stein
Journal:  Brain       Date:  2002-11       Impact factor: 13.501
View more
  7 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

3.  Motor and Nonmotor Circuitry Activation Induced by Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease: Intraoperative Functional Magnetic Resonance Imaging for Deep Brain Stimulation.

Authors:  Emily J Knight; Paola Testini; Hoon-Ki Min; William S Gibson; Krzysztof R Gorny; Christopher P Favazza; Joel P Felmlee; Inyong Kim; Kirk M Welker; Daniel A Clayton; Bryan T Klassen; Su-youne Chang; Kendall H Lee
Journal:  Mayo Clin Proc       Date:  2015-06       Impact factor: 7.616

4.  Effects of subthalamic deep brain stimulation on blink abnormalities of 6-OHDA lesioned rats.

Authors:  Jaime Kaminer; Pratibha Thakur; Craig Evinger
Journal:  J Neurophysiol       Date:  2015-02-11       Impact factor: 2.714

Review 5.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 6.  Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: An Institutional Experience and Review.

Authors:  Shazia Mirza; Umar Yazdani; Richard Dewey Iii; Neepa Patel; Richard B Dewey; Svjetlana Miocinovic; Shilpa Chitnis
Journal:  Parkinsons Dis       Date:  2017-06-19

Review 7.  Effects of Auditory Rhythm and Music on Gait Disturbances in Parkinson's Disease.

Authors:  Aidin Ashoori; David M Eagleman; Joseph Jankovic
Journal:  Front Neurol       Date:  2015-11-11       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.